Wilbur H. Gantz, Director at Aevi Genomic Medicine, Inc. (GNMX), bought 79,366 shares at $1.26 ($100K) on 2017-10-17, disclosed to the SEC on 2017-10-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.26 | 39,683 | $50K | 50.0% |
| 2 | $1.26 | 39,683 | $50K | 50.0% |
| Total | $1.26 avg | 79,366 | $100K | 100% |
| Filing → |
| GWW | SELL | 2012-11-26 | $376K | — | Filing → |
| GWW | SELL | 2011-10-21 | $276K | — | Filing → |
| GWW | SELL | 2010-11-01 | $297K | — | Filing → |